1. Home
  2. CRMD vs EZPW Comparison

CRMD vs EZPW Comparison

Compare CRMD & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • EZPW
  • Stock Information
  • Founded
  • CRMD 2006
  • EZPW 1989
  • Country
  • CRMD United States
  • EZPW United States
  • Employees
  • CRMD N/A
  • EZPW N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • EZPW Other Specialty Stores
  • Sector
  • CRMD Health Care
  • EZPW Consumer Discretionary
  • Exchange
  • CRMD Nasdaq
  • EZPW Nasdaq
  • Market Cap
  • CRMD 877.5M
  • EZPW 814.0M
  • IPO Year
  • CRMD 2010
  • EZPW 1991
  • Fundamental
  • Price
  • CRMD $11.64
  • EZPW $13.97
  • Analyst Decision
  • CRMD Strong Buy
  • EZPW Strong Buy
  • Analyst Count
  • CRMD 7
  • EZPW 3
  • Target Price
  • CRMD $17.33
  • EZPW $19.33
  • AVG Volume (30 Days)
  • CRMD 1.8M
  • EZPW 723.7K
  • Earning Date
  • CRMD 08-13-2025
  • EZPW 07-30-2025
  • Dividend Yield
  • CRMD N/A
  • EZPW N/A
  • EPS Growth
  • CRMD N/A
  • EZPW 23.23
  • EPS
  • CRMD 0.28
  • EZPW 1.29
  • Revenue
  • CRMD $82,553,827.00
  • EZPW $1,232,018,000.00
  • Revenue This Year
  • CRMD $278.96
  • EZPW $9.33
  • Revenue Next Year
  • CRMD $45.85
  • EZPW $6.46
  • P/E Ratio
  • CRMD $41.93
  • EZPW $10.86
  • Revenue Growth
  • CRMD N/A
  • EZPW 8.31
  • 52 Week Low
  • CRMD $3.61
  • EZPW $10.34
  • 52 Week High
  • CRMD $17.43
  • EZPW $16.60
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 47.40
  • EZPW 53.00
  • Support Level
  • CRMD $11.40
  • EZPW $13.08
  • Resistance Level
  • CRMD $12.02
  • EZPW $15.22
  • Average True Range (ATR)
  • CRMD 0.47
  • EZPW 0.42
  • MACD
  • CRMD 0.10
  • EZPW -0.00
  • Stochastic Oscillator
  • CRMD 68.61
  • EZPW 41.59

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Share on Social Networks: